COTY Leads Surge with 20.7% Gain as EPS Revisions Drive Rally
Stocks with upward EPS estimate revisions delivered strong gains, led by COTY (+20.7%) and RCEL (+18.7%). Coty benefited from a positive resolution to its Gucci license, while RCEL rose ahead of its Q2 earnings report. The moves underscore how earnings revisions can signal buying opportunities before price action confirms.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| COTY | Consumer Defensive | 2026-07-09 | N/A | +20.7% |
| RCEL | Healthcare | 2026-07-14 | N/A | +18.7% |
| RH | Consumer Cyclical | 2026-07-08 | N/A | +15.8% |
| BILL | Technology | 2026-07-08 | N/A | +12.5% |
| ROAD | Industrials | 2026-07-12 | N/A | +12.0% |
Why did COTY stock jump in July 2026?
COTY jumped 20.7% (from $2.13 to $2.57) after analysts raised its forward EPS growth estimate to 60.0% on July 9.
The gain was reinforced by the early termination of its Gucci license, which brought a $400 million cash payment and reduced uncertainty. Analysts at Jefferies and Barclays viewed the deal as better than a standard 2028 expiration, allowing Coty to pay down debt and invest in core brands. The consumer defensive sector provided a stable backdrop as investors rotated into value.
COTY EPS revision history → · Screener snapshot from 2026-07-09 →
FAQ: COTY
Why did COTY stock jump in July 2026?
COTY rose 20.7% from $2.13 to $2.57 after analysts boosted its forward EPS growth estimate to 60.0% on July 9, and the market welcomed the early termination of the Gucci license with a $400 million payment.
Is COTY a buy after the rally?
Analysts remain divided: Jefferies sees the Gucci cash as a positive for debt reduction, but the loss of Gucci Beauty (Coty's third-largest fragrance franchise) is a long-term headwind. The 60.0% EPS growth estimate suggests material recovery, but investors should weigh the portfolio transition.
What caused COTY's surge?
The surge was primarily driven by the upgrade in EPS estimates and the positive resolution of the Gucci license shift to L'Oréal, which removed uncertainty and provided $400 million in early cash payments.
Why did RCEL stock jump in July 2026?
RCEL surged 18.7% (from $4.02 to $4.77) after analysts revised its forward EPS growth estimate to 48.4% on July 14.
The move accelerated following the company's announcement that it will report Q2 2026 results on August 6, fueling optimism around its acute wound care pipeline. The healthcare sector broadly strengthened, and RCEL's position as a leader in regenerative wound healing drew investor interest ahead of earnings.
RCEL EPS revision history → · Screener snapshot from 2026-07-14 →
FAQ: RCEL
Why did RCEL stock jump in July 2026?
RCEL jumped 18.7% from $4.02 to $4.77 after its forward EPS growth estimate was raised to 48.4% on July 14, and the company scheduled its Q2 earnings call for August 6.
What is RCEL's EPS growth estimate?
RCEL's forward EPS growth estimate for the next year is 48.4%, reflecting higher profitability expectations for the acute wound care company.
What news drove RCEL's surge?
The surge was driven by the upward EPS revision and the announcement of second-quarter financial results on August 6, which heightened expectations for strong performance in its wound care product line.
Why did RH stock jump in July 2026?
RH rose 15.8% (from $162.59 to $188.24) after analysts raised its forward EPS growth estimate to 86.1% on July 8.
The move followed Goldman Sachs' upgrade to Neutral from Sell with a price target hike from $86 to $155, citing potential sales and margin improvement in 2027 despite ongoing earnings volatility. The consumer cyclical sector gained as housing-related stocks rebounded on signs of stabilizing demand.
RH EPS revision history → · Screener snapshot from 2026-07-08 →
FAQ: RH
Why did RH stock jump in July 2026?
RH jumped 15.8% from $162.59 to $188.24 after analysts boosted its forward EPS growth estimate to 86.1% on July 8, and Goldman Sachs upgraded the stock from Sell to Neutral.
What is RH's EPS growth estimate?
RH's forward EPS growth estimate for the next year is 86.1%, driven by expectations of stronger sales and margin improvement in 2027.
Is RH a buy after the rally?
Goldman Sachs upgraded RH to Neutral, but warns of ongoing earnings volatility, declining membership, and inventory risks. The 86.1% EPS growth estimate is aggressive, so investors should monitor execution.
Why did BILL stock jump in July 2026?
BILL gained 12.5% (from $39.30 to $44.20) after analysts raised its forward EPS growth estimate to 26.4% on July 8.
Although no company-specific news emerged, the technology sector saw broad rotation into software and fintech names on optimism about stabilizing spending. BILL has been restructuring its expense management platform, and the EPS revision signaled improving profitability ahead of upcoming earnings.
BILL EPS revision history → · Screener snapshot from 2026-07-08 →
FAQ: BILL
Why did BILL stock jump in July 2026?
BILL jumped 12.5% from $39.30 to $44.20 after analysts raised its forward EPS growth estimate to 26.4% on July 8, with sector rotation into fintech providing a tailwind.
What is BILL's EPS growth estimate?
BILL's forward EPS growth estimate for the next year is 26.4%, reflecting expectations of improved profitability in its expense management platform.
What caused BILL's surge?
The surge was driven primarily by the EPS estimate revision, as no specific news was released. Investors rotated into beaten-down technology stocks, betting on margin recoveries.
Why did ROAD stock jump in July 2026?
ROAD advanced 12.0% (from $94.89 to $106.30) after analysts raised its forward EPS growth estimate to 25.9% on July 12.
The company announced it will report fiscal Q3 results on August 7, reinforcing confidence in its infrastructure project pipeline across the Sunbelt. The industrials sector gained as heavy civil construction stocks benefited from state and federal funding flows.
ROAD EPS revision history → · Screener snapshot from 2026-07-12 →
FAQ: ROAD
Why did ROAD stock jump in July 2026?
ROAD jumped 12.0% from $94.89 to $106.30 after analysts raised its forward EPS growth estimate to 25.9% on July 12, ahead of its fiscal Q3 earnings release on August 7.
What is ROAD's EPS growth estimate?
ROAD's forward EPS growth estimate for the next year is 25.9%, driven by a strong backlog of publicly funded infrastructure projects in the Sunbelt.
What news drove ROAD's surge?
The surge was supported by the company's announcement of its fiscal Q3 earnings call on August 7, along with the EPS revision that highlighted growing confidence in its civil infrastructure operations.
Today's performers demonstrate that upward EPS estimate revisions—particularly when paired with clear catalysts like contract resolutions or upcoming earnings—can act as leading indicators for significant price gains. The breadth across sectors suggests investors are rewarding companies with visible earnings acceleration regardless of industry.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →